AI assistant
Sending…
Cellectar Biosciences, Inc. — Director's Dealing 2015
Nov 20, 2015
35021_dirs_2015-11-19_5d5d7623-5557-4f4d-8001-b4bc620d99b5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2015-11-18
Reporting Person: CARUSO JAMES V (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-18 | Common Stock, par value $0.00001 per share | P | 2000 | $1.3949 | Acquired | 2000 | Direct |
| 2015-11-19 | Common Stock, par value $0.00001 per share | P | 2000 | $1.5000 | Acquired | 4000 | Direct |
More from Cellectar Biosciences, Inc.
Regulatory Filings
2026
May 29
Proxy Solicitation & Information Statement
2026
May 28
Proxy Solicitation & Information Statement
2026
May 28
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Mar 4